BGC20-1531, a novel, potent and selective prostanoid EP(4) receptor antagonist: a putative new treatment for migraine headache

BACKGROUND AND PURPOSE: Prostanoid EP(4) receptor antagonists may have therapeutic utility in the treatment of migraine since EP(4) receptors have been shown to be involved in prostaglandin (PG)E(2)-induced cerebral vascular dilatation, which may be an important contributor to migraine pain. This st...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Maubach, KA, Davis, RJ, Clark, DE, Fenton, G, Lockey, PM, Clark, KL, Oxford, AW, Hagan, RM, Routledge, C, Coleman, RA
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Blackwell Publishing Ltd 2009
Konular:
Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2697835/
https://ncbi.nlm.nih.gov/pubmed/19154437
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1476-5381.2009.00027.x
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller